Overview

Metabolic Modulation as Treatment in Acute Heart Failure

Status:
Terminated
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate whether metabolic modulation improves hemodynamics and outcome in acute heart failure
Phase:
Phase 2
Details
Lead Sponsor:
University of Aarhus
Treatments:
Acipimox